RBR-5xbwjk已完成4 期
euromodulation applied to fibromyalgia (neurofibro): double-blind, controlled clinical trial - -:
niversidade Federal da Paraíba0 个研究点开始时间: 2020年6月24日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 60Y（—）
- 性别
- Female
入选标准
- •Having a diagnosis of fibromyalgia, according to the criteria of the American College of Rheumatology; having been diagnosed at least three months ago; be female; be in the age group between 27 and 58 years old; and signing the Informed Consent Form.
排除标准
- •Score below 24 on the Mini Mental State Examination; metal implants located on the head; cochlear implants and cardiac pacemaker; illiterate; pregnant women; history of seizure; and severe depression with a score greater than 35 in the Beck Depression Inventory.
研究者
相似试验
已完成
不适用
Efficacy of Non-invasive NESA Neuromodulation in FibromyalgiaFibromyalgiaNCT05648695University of Las Palmas de Gran Canaria12
招募中
Unknown
Development of a biomarker of fibromyalgia on neuroinflammation.Fibromyalgia, chronic painJPRN-UMIN000048852Department of Psychosomatic Medicine, Graduate School of Medical Sciences, Kyushu University80
已完成
不适用
Neurodynamic Intervention in FibromyalgiaFibromyalgiaNCT01826695Universidad de Granada48
已完成
不适用
Fibromyalgia Treatment With Enzyme DAOFibromyalgiaNCT05389761Centros de Investigación de Nutrición y Salud100
已完成
不适用
The efficacy of the Rességuier method in the treatment of fibromyalgia: a randomised controlled trialMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classifiedFibromyalgiaISRCTN62054712niversity of Florence (Italy)36